---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-016271"
form_type: "8-K"
ticker: "PETV"
cik: "0001512922"
company_name: "PetVivo Holdings, Inc."
filed_at: "2025-06-24T23:59:59+00:00"
generated_at: "2026-05-18T22:24:42.468028+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# PetVivo receives final $1M from $5M Series B Convertible Preferred Stock offering

## Summary
- Received $1M from full exercise of Purchase Option, completing $5M equity financing.
- Total of $5M raised via Series B Convertible Preferred Stock at $1 per share, convertible 1:1 into common stock.
- Proceeds intended for commercialization of Spryng and PrecisePRP, clinical trials, and working capital.
- Sale made under Section 4(a)(2) to accredited investor; shares are restricted.
- Certificate of Designation filed on March 26, 2025; amendment on March 31, 2025 for Company Call Option.

## SEC filing metadata
- accession: 0001641172-25-016271
- form_type: 8-K
- ticker: PETV
- cik: 0001512922
- company_name: PetVivo Holdings, Inc.
- filed_at: 2025-06-24T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1512922/000164117225016271/0001641172-25-016271-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1512922/000164117225016271/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-016271
- JSON: https://secwatch.observer/filing/0001641172-25-016271.json
- Plain text: https://secwatch.observer/filing/0001641172-25-016271.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.